Ellipsis Health
- Industry
- Health Technology
- Founded Year
- 2017
- Headquarters
- San Francisco, California, United States
- Employee Count
- 49
Key People
- Mainul Mondal - Founder & CEO
- Michael Aratow - Co-Founder & Chief Medical Officer
- Melissa McCool - Chief Operating Officer
- Angela Suthrave - Chief Product Officer
- Rafael Viturro - Chief Commercial Officer
- Elizabeth Shriberg - Chief Science Officer
- Ajit Verma - Chief Technology Officer
- Susan Solinsky - Co-Founder & Chief Growth Officer
Assessment
- Team
-
Aspect: Multiple successful MedTech entrepreneurs
Summary: The leadership team comprises experienced professionals with backgrounds in healthcare and technology.
The executive team includes individuals with significant experience in healthcare and technology sectors, enhancing the company's capability to innovate and execute effectively.
- Clinical Need
-
Aspect: Very Strong
Summary: Addressing the critical need for scalable mental health assessment tools.
With rising mental health issues and limited resources, Ellipsis Health's AI-driven assessments provide a timely and scalable solution to a significant healthcare challenge.
- Competition
-
Aspect: First mover
Summary: Pioneering AI-based vocal biomarker technology in mental health.
While leading innovation offers market advantages, it also involves risks related to market acceptance and the need for extensive education and validation.
- Technical Challenge
-
Aspect: Complex
Summary: Developing reliable AI models for mental health assessment is complex.
Creating accurate and ethical AI models for mental health requires overcoming significant technical and regulatory challenges, which could affect product development and deployment.
- Patent
-
Aspect: Strong
Summary: Possesses patented vocal biomarker technology.
Holding patents in vocal biomarker technology provides a barrier to entry for competitors and underscores the company's innovative capabilities.
- Financing
-
Aspect: Well-funded
Summary: Secured significant funding from reputable investors.
The $45 million Series A funding led by prominent investors like Salesforce Ventures and CVS Health Ventures provides the necessary capital for scaling operations and advancing technology.
- Regulatory
-
Aspect: 510k/PMA
Summary: Navigating complex regulatory pathways for AI in healthcare.
Ensuring compliance with healthcare regulations, including FDA approvals, is critical and may pose challenges in terms of time and resources.
Opportunity Rollup
- Odds of Success
- 3.1
- Peak Market Share
- 3.7
- Segment CAGR
- 9.5%
- Market Segment
- Mental Health Technology
- Market Sub Segment
- AI-based Diagnostic Tools
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.19 |
| 2 | 0.56 |
| 3 | 1.30 |
| 4 | 2.59 |
| 5 | 3.70 |
Key Takeaway
Ellipsis Health is well-positioned to address the growing need for scalable mental health assessment tools, leveraging strong leadership and innovative technology, though it faces challenges in competition and regulatory navigation.